DEN230064 is an FDA 510(k) submission (not cleared) for the BraidE Embolization Assist Device. Classified as Temporary Embolization Assist Device, Peripheral (product code QZU), Class II - Special Controls.
Submitted by Rapid Medical , Ltd. (Yokneam, IL). The FDA issued a Not Cleared (DENG) decision on February 21, 2024 after a review of 155 days.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3325 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway requires demonstration of substantial equivalence to a legally marketed predicate device - a standard the FDA determined was not met in this submission.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. This submission did not achieve clearance, indicating the FDA determined the device lacked sufficient predicate equivalence under the Cardiovascular review framework.